Literature DB >> 5552410

Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical studies of low and high density lipoproteins.

K R Norum, J A Glomset, A V Nichols, T Forte.   

Abstract

LOW DENSITY LIPOPROTEINS (LDL) AND HIGH DENSITY LIPOPROTEINS (HDL) FROM THE PLASMA OF PATIENTS WITH FAMILIAL LECITHIN: cholesterol acyltransferase (LCAT) deficiency have been characterized by gel filtration, analytical ultracentrifugation, and gel electrophoresis, and their relative content of lipid and protein has been determined. The LDL of d 1.019-1.063 g/ml show marked heterogeneity. A subfraction of the LDL emerges from columns of 2% agarose gel with the void volume, has corrected flotation rates (S(f) degrees ) in the range of 20-400, and contains 4-10 times as much unesterified cholesterol, phosphatidylcholine, and triglyceride per mg protein as normal LDL. A major subfraction of the LDL emerges from the gel in the same general position as normal LDL, but exhibits somewhat higher flotation rates and contains 1.5-3 times as much unesterified cholesterol and phosphatidylcholine and 13 times as much triglyceride per mg protein. The HDL, shown to be heterogeneous in earlier studies, are mainly comprised of molecules which have flotation rates of F(1.20) 3-20, migrate in the alpha(1)-alpha(2) region on electrophoresis, and contain about 12 times as much unesterified cholesterol and 5 times as much phosphatidylcholine per mg protein as normal HDL. Smaller molecules are also detected, which have flotation rates of F(1.20) 0-3, migrate in the prealbumin region on electrophoresis, and contain only slightly more unesterified cholesterol and phosphatidylcholine per mg protein than normal HDL.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5552410      PMCID: PMC292036          DOI: 10.1172/JCI106585

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer.

Authors:  R S LEES; F T HATCH
Journal:  J Lab Clin Med       Date:  1963-03

2.  A method for incorporating cholesterol and other lipides into serum lipoproteins in vitro.

Authors:  J AVIGAN
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

3.  Lipoproteins in primary biliary cirrhosis.

Authors:  E M RUSS; J RAYMUNT; D P BARR
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

4.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

Review 5.  Human serum lipoproteins and their interrelationships.

Authors:  A V Nichols
Journal:  Adv Biol Med Phys       Date:  1967

6.  Plasma lecithin-cholesterol acyltransferase and erythrocyte lipids in liver disease.

Authors:  E Gjone; K R Norum
Journal:  Acta Med Scand       Date:  1970-03-03

7.  Familial lecithin: cholesterol acyltransferase deficiency. Study of two new patients and their close relatives.

Authors:  K R Norum; S Borsting; I Grundt
Journal:  Acta Med Scand       Date:  1970-10

8.  Immunoassay of plasma low-density lipoproteins.

Authors:  R S Lees
Journal:  Science       Date:  1970-07-31       Impact factor: 47.728

9.  Familial plasma lecithin: cholesterol acyltransferase deficiency.

Authors:  B Hamnström; E Gjone; K R Norum
Journal:  Br Med J       Date:  1969-05-03

10.  A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

Authors:  D Seidel; P Alaupovic; R H Furman
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

View more
  17 in total

Review 1.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

2.  Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

Authors:  G Utermann; H J Menzel; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1975

3.  A robust all-atom model for LCAT generated by homology modeling.

Authors:  Jere P Segrest; Martin K Jones; Andrea Catte; Saravana P Thirumuruganandham
Journal:  J Lipid Res       Date:  2015-01-14       Impact factor: 5.922

Review 4.  Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.

Authors:  Maki Tsujita; Anna Wolska; Daniel A P Gutmann; Alan T Remaley
Journal:  Curr Atheroscler Rep       Date:  2018-11-05       Impact factor: 5.113

5.  Lipoproteins in LCAT-deficiency.

Authors:  G Utermann; W Schoenborn; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1972

6.  Alterations of rat serum lipoproteins and lecithin-cholesterol-acyltransferase activity in praseodymium-induced liver damage.

Authors:  O Grajewski; B von Lehmann; H R Arntz; P Arvela; E Oberdisse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

7.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency. Further studies of very low and low density lipoprotein abnormalities.

Authors:  J A Glomset; A V Nichols; K R Norum; W King; T Forte
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

Review 8.  High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

9.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by elctron microscopy.

Authors:  T Forte; K R Norum; J A Glomset; A V Nichols
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.